Duarte, California 91010

  • Stage IV Renal Cell Cancer AJCC v8

Purpose:

This trial tests the feasibility of an application (app)-based mindfulness intervention and its effect on improving quality of life in patients with renal cell cancer that has spread to other places in the body (metastatic). This trial aims to see whether an app-based mindfulness intervention may help patients cope with their disease.


Study summary:

PRIMARY OBJECTIVES: I. To assess feasibility of the Am mindfulness app in metastatic renal cell carcinoma (mRCC) patients, with respect to accrual, adherence and engagement in program. II. To assess preliminary effects of app-based mindfulness intervention in patients with metastatic renal cell carcinoma (mRCC) (the Am Mindfulness-Based Cancer Survivorship [MBCS] Journey), on psychosocial outcomes (e.g., anxiety, distress, fear of cancer recurrence), as well as overall quality of life (QOL) and fatigue, among patients with mRCC. OUTLINE: Patients participate in a mindfulness-based program by using the Am app for 20-30 minutes every day, a minimum of 4 days each week over 4 weeks.


Criteria:

Inclusion Criteria: - Sufficiently fluent in English - Cytologically or pathologically verified diagnosis of renal cell carcinoma (RCC) - Evidence of metastatic disease (including at a minimum computed tomography [CT] of the chest, abdomen and pelvis for staging) - Scheduled to undergo either first- or second- line therapy with immunotherapy - Have smart phone with internet access - Not suffering from current major depressive disorder, bipolar disorder or other psychiatric disorder - Not currently engaging in meditation one or more times per week within the previous year - Has not participated in an mindfulness-based cancer recovery (MBCR) or mindfulness-based stress reduction (MBSR) program in the past 5 years


NCT ID:

NCT04788095


Primary Contact:

Principal Investigator
Sumanta K Pal
City of Hope Medical Center


Backup Contact:

N/A


Location Contact:

Duarte, California 91010
United States

Sumanta K. Pal
Phone: 626-256-4673
Email: spal@coh.org

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: June 13, 2021

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.